Needham & Company
-
UPDATED PRESENTATION TIME FOR MAY 22: Medidata to Present at Upcoming Investor Conference
-
Medidata to Present at Upcoming Investor Conferences
-
Needham and Company Reiterates Buy Rating and $65 PT on Medidata Solutions (MDSO); 'Mytrus (Deal) to Expand Clinical Trial Impact'
-
Medidata Solutions (MDSO) PT Raised to $65 at Needham & Company on Positive 2017 Guidance
-
Needham & Company Reiterates Buy on Medidata Solutions (MDSO) Following Strong 2Q Results
-
Needham & Company Assumes Medidata Solutions (MDSO) at Buy
-
Needham & Company Remains Bullish on Medidata Solutions (MDSO) Despite Revenue Shortfall
-
Medidata and Validic Integrate Cloud Technology Platforms, Expanding Mobile Health Ecosystem to Drive Innovative, Patient-Centric Research
-
Medidata and Validic Integrate Cloud Technology Platforms, Expanding Mobile Health Ecosystem to Drive Innovative, Patient-Centric Research
-
Medidata Solutions (MDSO) PT Raised to $65 at Needham & Company
-
Unusual 11 Mid-Day Movers 04/29: (OSH) (WRLS) (GALT) Higher; (LAS) (NTE) (GWAY) Lower
-
Needham & Company has Upbeat Travels with Medidata Solutions (MDSO); Shares Still 'Underappreciated'
-
Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Fire Flame...$100 Million Dollars
-
Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Favorable Demand Environment
-
Unusual 11 Mid-Day Movers 03/23: (DEXO) (CPWM) (GLUU) Higher; (BONE) (KITD) (GSB) Lower
-
Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Mixed Q3 But Likely Good Enough Given Accelerating 2012 Ahead
-
Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Muted App Revenue But Inline Guidance and Other Encouraging Signs
-
Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); NCI Not a Total or Permanent Loss; Recommend Buying Shares on Weakness
-
Needham & Company Starts Medidata Solutions (MDSO) at Buy; “SaaSifying” The Clinical Trials World
-
Medidata Solutions (MDSO) Prices Secondary Offering at $15 Per Share
-
Medidata Solutions (MDSO) Announces 4.5M Common Offering by Selling Shareholders
-
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded
-
Needham & Co Initiates Coverage on Medidata Solutions (MDSO) with a Buy
-
Medidata Solutions (MDSO) IPO Jumps Higher
-
Medidata Solutions (MDSO) Prices 6.3M IPO at $14, Above Expected Range

